Upgrade to SI Premium - Free Trial

BioLineRx (BLRX)

2.06 -0.05 (2.37%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/14/26 *Est.)

Latest Headlines

BioLineRx and Hemispherian to present GLIX1 data at SNO meeting October 8, 2026 7:03 AM - StreetInsider BioLineRx and Hemispherian Announce Two GLIX1 Presentations at the 31st Society for Neuro-Oncology (SNO) Annual Meeting & Education Day October 8, 2026 7:00 AM - PR NewsWire Form EFFECT BioLineRx Ltd. October 5, 2026 6:04 AM - SEC Filing Form 424B3 BioLineRx Ltd. October 2, 2026 5:01 PM - SEC Filing Form F-1 BioLineRx Ltd. September 25, 2026 4:31 PM - SEC Filing Form 6-K BioLineRx Ltd. For: Sep 24 September 24, 2026 4:06 PM - SEC Filing BioLineRx and Hemispherian to present GLIX1 data at EANO 2026 September 10, 2026 7:00 AM - StreetInsider Form 6-K BioLineRx Ltd. For: Sep 10 September 10, 2026 7:00 AM - SEC Filing BioLineRx and Hemispherian AS to Present Encouraging GLIX1 Preclinical Efficacy Data and its Phase 1/2a Trial Design at the 21st Meeting of the European Association of Neuro-Oncology (EANO 2026) September 10, 2026 7:00 AM - PR NewsWire Form 6-K BioLineRx Ltd. For: Aug 28 August 28, 2026 8:12 AM - SEC Filing BioLineRx plans $3.75M share offering at $2.78 per ADS August 28, 2026 8:00 AM - StreetInsider BioLineRx Announces $3.75 Million Registered Direct Offering and Concurrent Private Placement August 28, 2026 8:00 AM - PR NewsWire BioLineRx to Report Second Quarter 2026 Results on August 31, 2026 August 25, 2026 7:00 AM - PR NewsWire Form 6-K BioLineRx Ltd. For: Aug 18 August 18, 2026 4:04 PM - SEC Filing Full Article List